These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 32687756)
1. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement. Paladugu S; Donato AA Ann Intern Med; 2020 Jul; 173(2):JC4. PubMed ID: 32687756 [TBL] [Abstract][Full Text] [Related]
2. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
3. Audio Interview: New Data on Remdesivir in Covid-19. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948 [No Abstract] [Full Text] [Related]
4. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516 [No Abstract] [Full Text] [Related]
5. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019. Montastruc F; Thuriot S; Durrieu G Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580 [TBL] [Abstract][Full Text] [Related]
7. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective. Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232 [No Abstract] [Full Text] [Related]
8. [Chloroquine as a possible treatment for COVID-19]. Coumou J; de Vries PJ Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999 [TBL] [Abstract][Full Text] [Related]
9. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. Sun D AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279 [TBL] [Abstract][Full Text] [Related]
10. Kidney Transplantation and COVID-19. Merhi B; Gohh R R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010 [No Abstract] [Full Text] [Related]
11. [Remdesivir for patients with severe COVID-19]. Augustin M; Hallek M; Nitschmann S Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086 [No Abstract] [Full Text] [Related]
12. Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza. Anderson PO Breastfeed Med; 2020 Mar; 15(3):128. PubMed ID: 32129667 [No Abstract] [Full Text] [Related]
13. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. Ison MG; Wolfe C; Boucher HW JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438 [No Abstract] [Full Text] [Related]
14. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19. Chua KP; Conti RM JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187 [No Abstract] [Full Text] [Related]
15. [Not Available]. Fumeaux T Rev Med Suisse; 2020 Jun; 16(697):1220. PubMed ID: 32520466 [No Abstract] [Full Text] [Related]
16. Antiviral treatment for COVID-19: the evidence supporting remdesivir. Richardson C; Bhagani S; Pollara G Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273 [TBL] [Abstract][Full Text] [Related]
17. Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Martinez MA Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826 [TBL] [Abstract][Full Text] [Related]
18. Uncertainty about the Efficacy of Remdesivir on COVID-19. Yoo JH J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956 [No Abstract] [Full Text] [Related]